Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?<sup>1</sup>

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?<sup>1</sup>

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?<sup>1</sup>

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control